BIOLASE reports under the terms of the private placement, BIOLASE has agreed to sell an aggregate of 80,644 shares of a newly created series of its convertible preferred stock at a per share price of $124.00.
The investment brings Neural Analytics’ total funding to $27 million. Ted Koutouzis, M.D. of Reimagined Ventures will join Neural Analytics’ Board of Directors.
Vascular Dynamics, Inc., (VDI) a privately held medical device company developing novel solutions for the treatment of hypertension, today announces it has completed a $10.4 million financing. The private placement included all major current investors in Vascular Dynamics. ...
Cardiva Medical Raises $30 Million: Financing to Be Used for Commercial Expansion of the VASCADE Vascular Closure System
The financing will be used to continue the rapid commercial expansion of the VASCADE® Vascular Closure System and to fund Cardiva’s proprietary, next-generation closure technologies that are in development.